FINWIRES · TerminalLIVE
FINWIRES

Evercore's Valuation Discount to Peers Could Narrow, Deutsche Bank Says

By

Evercore's (EVR) valuation "discount to peers" could narrow as continued "revenue momentum," advisory market-share gains, stable margins and moderating non-compensation cost growth support a re-rating of the shares, Deutsche Bank said in a report Friday.

Evercore shares are down about 15% this year, compared with an 11% decline for the peer group, with much of the "underperformance" following the company's Q2 results in late July. The stock now trades at about 13 times 2027 consensus earnings, a 10% to 15% "discount to peers" versus a historical discount of 3% to 5%, according to the note.

Deutsche Bank said concerns about a "late cycle" environment, below-average earnings growth expectations and structurally "higher cost ratios" have weighed on the shares, the note added.

Deutsche Bank has a buy rating on Evercore with a price target of $375.

Price: $296.27, Change: $-0.64, Percent Change: -0.22%

Related Articles

Wire

Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data

Vaxcyte (PCVX) appointed Luis Jodar as chief medical officer and David McAvoy as chief legal officer, the company said on Thursday.Jodar spent 17 years at Pfizer (PFE), most recently as senior vice president and chief medical officer for Vaccines and Infectious Diseases, the company said.McAvoy joins the company from Teva Pharmaceutical (TEVA), according to a statement.The vaccine developer also said it now expects to report topline data from its phase 3 OPUS-1 trial of VAX-31 in adults by the end of October, narrowing its previous guidance of a Q4 data release.

$PCVX
Wire

eGain Fiscal Q4 Adjusted Earnings, Revenue Fall; Shares Slump After Hours

EGain (EGAN) reported fiscal Q4 adjusted earnings late Thursday of $0.08 per diluted share, down from $0.09 a year earlier.Three analysts polled by FactSet projected $0.03.Revenue in the three months ended June 30 fell to $22.2 million from $23.2 million a year earlier.Three analysts projected $21.7 million.The company expects fiscal Q1 adjusted EPS of $0.05 to $0.08 on revenue of $20.9 million to $21.4 million. Three analysts project EPS of $0.08 on revenue of $22.3 million.For fiscal 2027, eGain expects adjusted EPS of $0.04 to $0.07 on revenue of $84.5 million to $86 million. Three analysts project EPS of $0.43 on revenue of $94.1 million.EGain shares slumped 29% in after-hours trading.

$EGAN
Wire

American Outdoor Brands Fiscal Q1 Swings to Adjusted Earnings, Revenue Rises

American Outdoor Brands (AOUT) reported fiscal Q1 non-GAAP earnings late Thursday of $0.03 per diluted share, swinging from a loss $0.26 year earlier.Two analysts polled by FactSet expected a loss of $0.24.Net sales for the quarter ended July 31 were $37.3 million, up from $29.7 million a year earlier.Two analysts expected $35.6 million.For fiscal 2027, the company maintained its net sales forecast of $200 million to $210 million. Two analysts expect $205.1 million.Shares of the company rose over 16% in after-hours trading.

$AOUT